NYSE · AGRICULTURAL CHEMICALS · LARGE CAP
Scotts Miracle-Gro Co. SMG
18 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$3.4B
▼ 3.9% vs FY2024
EPS · FY25
$2.47
Dividend / sh · FY25
$2.64
Payout · FY25
106%
ROE · FY25
—
Net margin · FY25
4.3%
Dividend coverage
0.9×
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 3.4B
Revenue, FY2025 · full 18-year series below
Revenue
Net income
4 cents of every revenue dollar became profit this year.
Per share
USD 2.47
Diluted EPS, FY2025
EPS
Dividend
Earnings covered only a fraction of the dividend — the rest came from cash or borrowing.
Profitability
—
Return on equity, FY2025
ROE
Operating margin10.5%
Net margin4.3%
Return on assets5.2%
Returned to shareholders
USD 160.8M
returned in FY2025 · dividends + net buybacks
Dividends paidUSD 154.3M
Net buybacksUSD 6.5M
Share of profit110.7%
Consecutive raises—
USD 154.3M in dividends and USD 6.5M in buybacks — 111% of the year's profit, so the payout drew on cash built up earlier.
Growth
−3.7% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
−4.5%
−3.7%
+3.7%
+1.2%
Net income
−17.8%
−1.0%
−2.2%
EPS, diluted
−18.4%
−0.4%
−1.3%
Dividend / share
+0.0%
−18.5%
+3.8%
+6.3%
Returned to shareholders
−27.4%
−18.5%
+3.7%
+8.8%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.06B
Shares outstanding, FY2025
Change, 5 years+2.3%
Change, 10 years−5.9%
The share count grew 2% in five years — the same company, cut into more, smaller slices.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 2.7B
total assets, end of FY2025
Total assetsUSD 2.7B
CashUSD 36.6M
Gross debtUSD 2.1B
Net debtUSD 2.1B
Current ratio1.27×
History
18 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
Revenue $B
3.4
3.6
3.6
3.9
4.9
4.1
3.2
2.7
2.6
2.5
2.4
2.6
2.8
2.8
2.8
2.9
2.7
2.8
Operating income $B
0.4
0.2
−0.2
−0.4
0.7
0.6
0.4
0.2
0.4
0.4
0.3
0.3
0.3
0.2
0.3
0.4
0.3
0.1
EBITDA $B
0.4
0.3
−0.1
−0.4
0.8
0.6
0.5
0.3
0.5
0.5
0.3
0.3
0.4
0.3
0.3
0.4
0.3
0.2
Income tax $B
0.1
0.0
−0.1
−0.1
0.2
0.1
0.1
−0.0
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.0
Net income $B
0.1
−0.0
−0.4
−0.4
0.5
0.4
0.5
0.1
0.2
0.3
0.2
0.2
0.2
0.1
0.2
0.2
0.2
−0.0
EPS, diluted $
2.47
−0.61
−6.79
−7.88
8.96
6.81
8.18
1.12
3.63
5.09
2.57
2.65
2.57
1.71
2.54
3.02
2.32
−0.17
Dividend / sh $
2.64
2.64
2.64
2.64
2.52
7.36
2.23
2.14
2.03
1.91
1.82
3.76
1.41
1.23
1.05
1.05
0.50
0.50
Payout %
106
−434
−39
−38
28
106
27
188
55
37
70
139
55
71
40
21
22
−298
ROE %
·
·
·
−43.2
59.9
54.7
85.8
12.7
32.0
47.2
27.2
26.3
24.6
18.3
25.4
30.3
30.0
−2.5
Shares out B
0.06
0.06
0.06
0.06
0.06
·
0.06
0.06
0.06
0.06
0.06
0.06
0.06
0.06
0.06
0.07
0.07
·
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
59 of 69
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 10 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed